0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Research Report 2023
Published Date: June 2023
|
Report Code: QYRE-Auto-11V14940
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Research Report 2023
BUY CHAPTERS

Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Research Report 2023

Code: QYRE-Auto-11V14940
Report
June 2023
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Grade Nicotinamide Mononucleotide Market Size

According to QYResearch’s new survey, global Pharmaceutical Grade Nicotinamide Mononucleotide market is projected to reach US$ 635.9 million in 2029, increasing from US$ 519.3 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2029.

Pharmaceutical Grade Nicotinamide Mononucleotide Market

Pharmaceutical Grade Nicotinamide Mononucleotide Market

Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Grade Nicotinamide Mononucleotide market research.
Key manufacturers engaged in the Pharmaceutical Grade Nicotinamide Mononucleotide industry include GeneHarbor, Herbalmax, Shinkowa, EffePharm, Mirailab Bioscience, Bangtai Bio, Jindawei and Hongboyuan Life Technology, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
For production bases, global Pharmaceutical Grade Nicotinamide Mononucleotide production is dominated by and . The two regions contributed to % production share globally in 2022.
When refers to consumption region, % volume of Pharmaceutical Grade Nicotinamide Mononucleotide were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pharmaceutical Grade Nicotinamide Mononucleotide market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmaceutical Grade Nicotinamide Mononucleotide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Pharmaceutical Grade Nicotinamide Mononucleotide Market Report

Report Metric Details
Report Name Pharmaceutical Grade Nicotinamide Mononucleotide Market
Accounted market size in 2022 US$ 519.3 million
Forecasted market size in 2029 US$ 635.9 million
CAGR 3.2%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Concentration≥98%
  • Concentration<98%
Segment by Application
  • Health Products
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GeneHarbor, Herbalmax, Shinkowa, EffePharm, Mirailab Bioscience, Bangtai Bio, Jindawei, Hongboyuan Life Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Pharmaceutical Grade Nicotinamide Mononucleotide Market market growing?

Ans: The Pharmaceutical Grade Nicotinamide Mononucleotide Market market witnessing a CAGR of 3.2% during the forecast period 2023-2029.

What is the Pharmaceutical Grade Nicotinamide Mononucleotide Market market size in 2029?

Ans: According to QYResearch’s new survey, global Pharmaceutical Grade Nicotinamide Mononucleotide market is projected to reach US$ 635.9 million in 2029, increasing from US$ 519.3 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2029.

1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Nicotinamide Mononucleotide Segment by Type
1.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Concentration≥98%
1.2.3 Concentration<98%
1.3 Pharmaceutical Grade Nicotinamide Mononucleotide Segment by Application
1.3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Health Products
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Estimates and Forecasts (2018-2029)
1.4.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Manufacturers (2018-2023)
2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Pharmaceutical Grade Nicotinamide Mononucleotide, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Pharmaceutical Grade Nicotinamide Mononucleotide Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Date of Enter into This Industry
2.9 Pharmaceutical Grade Nicotinamide Mononucleotide Market Competitive Situation and Trends
2.9.1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical Grade Nicotinamide Mononucleotide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical Grade Nicotinamide Mononucleotide Production by Region
3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region (2018-2029)
3.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Pharmaceutical Grade Nicotinamide Mononucleotide by Region (2024-2029)
3.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Region (2018-2029)
3.4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Pharmaceutical Grade Nicotinamide Mononucleotide by Region (2024-2029)
3.5 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Price Analysis by Region (2018-2023)
3.6 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2018-2029)
4 Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region
4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2018-2029)
4.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2018-2023)
4.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2018-2029)
5.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2018-2023)
5.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2024-2029)
5.1.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Type (2018-2029)
5.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2018-2029)
5.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2018-2023)
5.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2024-2029)
5.2.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Type (2018-2029)
5.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Type (2018-2029)
6 Segment by Application
6.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2018-2029)
6.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2018-2023)
6.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2024-2029)
6.1.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Application (2018-2029)
6.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2018-2029)
6.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2018-2023)
6.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2024-2029)
6.2.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Application (2018-2029)
6.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Application (2018-2029)
7 Key Companies Profiled
7.1 GeneHarbor
7.1.1 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.1.2 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.1.3 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.1.4 GeneHarbor Main Business and Markets Served
7.1.5 GeneHarbor Recent Developments/Updates
7.2 Herbalmax
7.2.1 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.2.2 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.2.3 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Herbalmax Main Business and Markets Served
7.2.5 Herbalmax Recent Developments/Updates
7.3 Shinkowa
7.3.1 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.3.2 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.3.3 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Shinkowa Main Business and Markets Served
7.3.5 Shinkowa Recent Developments/Updates
7.4 EffePharm
7.4.1 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.4.2 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.4.3 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.4.4 EffePharm Main Business and Markets Served
7.4.5 EffePharm Recent Developments/Updates
7.5 Mirailab Bioscience
7.5.1 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.5.2 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.5.3 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Mirailab Bioscience Main Business and Markets Served
7.5.5 Mirailab Bioscience Recent Developments/Updates
7.6 Bangtai Bio
7.6.1 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.6.2 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.6.3 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Bangtai Bio Main Business and Markets Served
7.6.5 Bangtai Bio Recent Developments/Updates
7.7 Jindawei
7.7.1 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.7.2 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.7.3 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Jindawei Main Business and Markets Served
7.7.5 Jindawei Recent Developments/Updates
7.8 Hongboyuan Life Technology
7.8.1 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.8.2 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.8.3 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Hongboyuan Life Technology Main Business and Markets Served
7.7.5 Hongboyuan Life Technology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Chain Analysis
8.2 Pharmaceutical Grade Nicotinamide Mononucleotide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical Grade Nicotinamide Mononucleotide Production Mode & Process
8.4 Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Marketing
8.4.1 Pharmaceutical Grade Nicotinamide Mononucleotide Sales Channels
8.4.2 Pharmaceutical Grade Nicotinamide Mononucleotide Distributors
8.5 Pharmaceutical Grade Nicotinamide Mononucleotide Customers
9 Pharmaceutical Grade Nicotinamide Mononucleotide Market Dynamics
9.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Trends
9.2 Pharmaceutical Grade Nicotinamide Mononucleotide Market Drivers
9.3 Pharmaceutical Grade Nicotinamide Mononucleotide Market Challenges
9.4 Pharmaceutical Grade Nicotinamide Mononucleotide Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
    Table 1. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Type, (US$ Million) & (2022 VS 2029)
    Table 2. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Application, (US$ Million) & (2022 VS 2029)
    Table 3. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Capacity (Tons) by Manufacturers in 2022
    Table 4. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Manufacturers (2018-2023) & (Tons)
    Table 5. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Manufacturers (2018-2023)
    Table 6. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Manufacturers (2018-2023) & (US$ Million)
    Table 7. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Share by Manufacturers (2018-2023)
    Table 8. Global Pharmaceutical Grade Nicotinamide Mononucleotide Industry Ranking 2021 VS 2022 VS 2023
    Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Grade Nicotinamide Mononucleotide as of 2022)
    Table 10. Global Market Pharmaceutical Grade Nicotinamide Mononucleotide Average Price by Manufacturers (US$/Ton) & (2018-2023)
    Table 11. Manufacturers Pharmaceutical Grade Nicotinamide Mononucleotide Production Sites and Area Served
    Table 12. Manufacturers Pharmaceutical Grade Nicotinamide Mononucleotide Product Types
    Table 13. Global Pharmaceutical Grade Nicotinamide Mononucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Mergers & Acquisitions, Expansion
    Table 15. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 16. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Region (2018-2023)
    Table 17. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Region (2018-2023)
    Table 18. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Forecast by Region (2024-2029)
    Table 19. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share Forecast by Region (2024-2029)
    Table 20. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Comparison by Region: 2018 VS 2022 VS 2029 (Tons)
    Table 21. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Region (2018-2023)
    Table 22. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Region (2018-2023)
    Table 23. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) Forecast by Region (2024-2029)
    Table 24. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share Forecast by Region (2024-2029)
    Table 25. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Average Price (US$/Ton) by Region (2018-2023)
    Table 26. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Average Price (US$/Ton) by Region (2024-2029)
    Table 27. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (Tons)
    Table 28. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2018-2023) & (Tons)
    Table 29. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Region (2018-2023)
    Table 30. Global Pharmaceutical Grade Nicotinamide Mononucleotide Forecasted Consumption by Region (2024-2029) & (Tons)
    Table 31. Global Pharmaceutical Grade Nicotinamide Mononucleotide Forecasted Consumption Market Share by Region (2018-2023)
    Table 32. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)
    Table 33. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2018-2023) & (Tons)
    Table 34. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2024-2029) & (Tons)
    Table 35. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)
    Table 36. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2018-2023) & (Tons)
    Table 37. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2024-2029) & (Tons)
    Table 38. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (Tons)
    Table 39. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2018-2023) & (Tons)
    Table 40. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2024-2029) & (Tons)
    Table 41. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)
    Table 42. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2018-2023) & (Tons)
    Table 43. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2024-2029) & (Tons)
    Table 44. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Type (2018-2023)
    Table 45. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Type (2024-2029)
    Table 46. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Type (2018-2023)
    Table 47. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Type (2024-2029)
    Table 48. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Type (2018-2023)
    Table 49. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Type (2024-2029)
    Table 50. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Share by Type (2018-2023)
    Table 51. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Share by Type (2024-2029)
    Table 52. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Type (2018-2023)
    Table 53. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Type (2024-2029)
    Table 54. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Application (2018-2023)
    Table 55. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Application (2024-2029)
    Table 56. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Application (2018-2023)
    Table 57. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Application (2024-2029)
    Table 58. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Application (2018-2023)
    Table 59. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Application (2024-2029)
    Table 60. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Share by Application (2018-2023)
    Table 61. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Share by Application (2024-2029)
    Table 62. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Application (2018-2023)
    Table 63. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Application (2024-2029)
    Table 64. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
    Table 65. GeneHarbor Specification and Application
    Table 66. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
    Table 67. GeneHarbor Main Business and Markets Served
    Table 68. GeneHarbor Recent Developments/Updates
    Table 69. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
    Table 70. Herbalmax Specification and Application
    Table 71. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
    Table 72. Herbalmax Main Business and Markets Served
    Table 73. Herbalmax Recent Developments/Updates
    Table 74. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
    Table 75. Shinkowa Specification and Application
    Table 76. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
    Table 77. Shinkowa Main Business and Markets Served
    Table 78. Shinkowa Recent Developments/Updates
    Table 79. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
    Table 80. EffePharm Specification and Application
    Table 81. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
    Table 82. EffePharm Main Business and Markets Served
    Table 83. EffePharm Recent Developments/Updates
    Table 84. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
    Table 85. Mirailab Bioscience Specification and Application
    Table 86. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
    Table 87. Mirailab Bioscience Main Business and Markets Served
    Table 88. Mirailab Bioscience Recent Developments/Updates
    Table 89. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
    Table 90. Bangtai Bio Specification and Application
    Table 91. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
    Table 92. Bangtai Bio Main Business and Markets Served
    Table 93. Bangtai Bio Recent Developments/Updates
    Table 94. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
    Table 95. Jindawei Specification and Application
    Table 96. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
    Table 97. Jindawei Main Business and Markets Served
    Table 98. Jindawei Recent Developments/Updates
    Table 99. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
    Table 100. Hongboyuan Life Technology Specification and Application
    Table 101. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
    Table 102. Hongboyuan Life Technology Main Business and Markets Served
    Table 103. Hongboyuan Life Technology Recent Developments/Updates
    Table 104. Key Raw Materials Lists
    Table 105. Raw Materials Key Suppliers Lists
    Table 106. Pharmaceutical Grade Nicotinamide Mononucleotide Distributors List
    Table 107. Pharmaceutical Grade Nicotinamide Mononucleotide Customers List
    Table 108. Pharmaceutical Grade Nicotinamide Mononucleotide Market Trends
    Table 109. Pharmaceutical Grade Nicotinamide Mononucleotide Market Drivers
    Table 110. Pharmaceutical Grade Nicotinamide Mononucleotide Market Challenges
    Table 111. Pharmaceutical Grade Nicotinamide Mononucleotide Market Restraints
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Pharmaceutical Grade Nicotinamide Mononucleotide
    Figure 2. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Type, (US$ Million) & (2022 VS 2029)
    Figure 3. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Type: 2022 VS 2029
    Figure 4. Concentration≥98% Product Picture
    Figure 5. Concentration<98% Product Picture
    Figure 6. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Application, (US$ Million) & (2022 VS 2029)
    Figure 7. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application: 2022 VS 2029
    Figure 8. Health Products
    Figure 9. Others
    Figure 10. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million), 2018 VS 2022 VS 2029
    Figure 11. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) & (2018-2029)
    Figure 12. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Capacity (Tons) & (2018-2029)
    Figure 13. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) & (2018-2029)
    Figure 14. Global Pharmaceutical Grade Nicotinamide Mononucleotide Average Price (US$/Ton) & (2018-2029)
    Figure 15. Pharmaceutical Grade Nicotinamide Mononucleotide Report Years Considered
    Figure 16. Pharmaceutical Grade Nicotinamide Mononucleotide Production Share by Manufacturers in 2022
    Figure 17. Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 18. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Grade Nicotinamide Mononucleotide Revenue in 2022
    Figure 19. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Figure 20. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Region: 2018 VS 2022 VS 2029
    Figure 21. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Comparison by Region: 2018 VS 2022 VS 2029 (Tons)
    Figure 22. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Region: 2018 VS 2022 VS 2029
    Figure 23. North America Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2018-2029)
    Figure 24. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2018-2029)
    Figure 25. China Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2018-2029)
    Figure 26. Japan Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2018-2029)
    Figure 27. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region: 2018 VS 2022 VS 2029 (Tons)
    Figure 28. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Region: 2018 VS 2022 VS 2029
    Figure 29. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 30. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Country (2018-2029)
    Figure 31. Canada Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 32. U.S. Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 33. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 34. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Country (2018-2029)
    Figure 35. Germany Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 36. France Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 37. U.K. Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 38. Italy Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 39. Russia Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 40. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 41. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Regions (2018-2029)
    Figure 42. China Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 43. Japan Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 44. South Korea Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 45. China Taiwan Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 46. Southeast Asia Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 47. India Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 48. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 49. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Country (2018-2029)
    Figure 50. Mexico Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 51. Brazil Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 52. Turkey Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 53. GCC Countries Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2018-2023) & (Tons)
    Figure 54. Global Production Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2018-2029)
    Figure 55. Global Production Value Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2018-2029)
    Figure 56. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Type (2018-2029)
    Figure 57. Global Production Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Application (2018-2029)
    Figure 58. Global Production Value Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Application (2018-2029)
    Figure 59. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Application (2018-2029)
    Figure 60. Pharmaceutical Grade Nicotinamide Mononucleotide Value Chain
    Figure 61. Pharmaceutical Grade Nicotinamide Mononucleotide Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS